Found: 77
Select item for more details and to access through your institution.
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 833, doi. 10.1002/ajh.26527
- By:
- Publication type:
- Article
Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 560, doi. 10.1002/ajh.24346
- By:
- Publication type:
- Article
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 778, doi. 10.1002/ajh.24082
- By:
- Publication type:
- Article
The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 633, doi. 10.1002/ajh.23708
- By:
- Publication type:
- Article
Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 10, p. 810, doi. 10.1002/ajh.21818
- By:
- Publication type:
- Article
The evolving role of response-adapted PET imaging in Hodgkin lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 2, p. 108, doi. 10.1177/2040620715625615
- By:
- Publication type:
- Article
Sociodemographic and Health Correlates of Multiple Health Behavior Adherence among Cancer Survivors: A Latent Class Analysis.
- Published in:
- Nutrients, 2023, v. 15, n. 10, p. 2354, doi. 10.3390/nu15102354
- By:
- Publication type:
- Article
A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170521
- By:
- Publication type:
- Article
Scaffold-mediated switching of lymphoma metabolism in culture.
- Published in:
- Cancer & Metabolism, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40170-022-00291-y
- By:
- Publication type:
- Article
Dynamic analysis of human natural Killer cell response at single-cell resolution in B-cell non-hodgkin lymphoma.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01736
- By:
- Publication type:
- Article
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e435, doi. 10.1016/j.clml.2021.12.012
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
- By:
- Publication type:
- Article
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Current Treatment Options for Older Patients with Hodgkin Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3662, doi. 10.1002/cncr.28243
- By:
- Publication type:
- Article
Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 15, p. 3743, doi. 10.1002/cncr.26709
- By:
- Publication type:
- Article
Health-related quality of life in Hodgkin lymphoma: a systematic review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41419-023-06299-6
- By:
- Publication type:
- Article
Improving Outcomes in PTLD.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 944
- By:
- Publication type:
- Article
Primary Cutaneous and Systemic Anaplastic Large Cell Lymphoma: Clinicopathologic Aspects and Therapeutic Options.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 7, p. 574
- By:
- Publication type:
- Article
Hodgkin Lymphoma in Older Patients; An Uncommon Disease in Need of Study.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1369
- By:
- Publication type:
- Article
An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2720, doi. 10.3390/biomedicines10112720
- By:
- Publication type:
- Article
Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52985-x
- By:
- Publication type:
- Article
Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11098-5
- By:
- Publication type:
- Article
XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.
- Published in:
- Hematological Oncology, 2013, v. 31, p. 69, doi. 10.1002/hon.2070
- By:
- Publication type:
- Article
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08120-8
- By:
- Publication type:
- Article
SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.
- Published in:
- 2021
- By:
- Publication type:
- journal article
End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 333, doi. 10.1111/bjh.18217
- By:
- Publication type:
- Article
First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 222, doi. 10.1111/bjh.16525
- By:
- Publication type:
- Article
Combinatorial ixazomib and belinostat therapy induces NFE2L2‐dependent apoptosis in Hodgkin and T‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 2, p. 295, doi. 10.1111/bjh.16160
- By:
- Publication type:
- Article
Important new developments in Hodgkin Lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 1, p. 6, doi. 10.1111/bjh.15736
- By:
- Publication type:
- Article
Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 212, doi. 10.1111/bjh.15255
- By:
- Publication type:
- Article
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 264, doi. 10.1111/bjh.14544
- By:
- Publication type:
- Article
How I manage patients with grey zone lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 3, p. 345, doi. 10.1111/bjh.14174
- By:
- Publication type:
- Article
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone ( CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma ( PTCL): final results from the T- cell consortium trial.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 535, doi. 10.1111/bjh.13855
- By:
- Publication type:
- Article
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 4, p. 514, doi. 10.1111/bjh.12915
- By:
- Publication type:
- Article
F-18 FDG- PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 793, doi. 10.1111/bjh.12824
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
Pre-diagnosis cigarette smoking and overall survival in non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 352, doi. 10.1111/bjh.12512
- By:
- Publication type:
- Article
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 55, doi. 10.1111/bjh.12488
- By:
- Publication type:
- Article
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 1, p. 76, doi. 10.1111/bjh.12222
- By:
- Publication type:
- Article
Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia ( AML).
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 262, doi. 10.1111/bjh.12109
- By:
- Publication type:
- Article
Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 196, doi. 10.1111/j.1365-2141.2011.08934.x
- By:
- Publication type:
- Article
Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms.
- Published in:
- 2010
- By:
- Publication type:
- Letter
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 158, doi. 10.1111/j.1365-2141.2010.08209.x
- By:
- Publication type:
- Article
Novel Targeted Agents for the Treatment of Hodgkin Lymphoma.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2010, v. 18, n. 1, p. 1
- By:
- Publication type:
- Article